Proliferative features of IgG4-related disease
- PMID: 38574744
- DOI: 10.1016/S2665-9913(24)00022-5
Proliferative features of IgG4-related disease
Abstract
IgG4-related disease is an immune-mediated disease that can lead to substantial morbidity and organ damage. Capable of affecting nearly any organ system or anatomic site, and showing considerable overlap in clinical presentation with various other diseases, IgG4-related disease often poses a diagnostic challenge for clinicians. Furthermore, there are no diagnostic biomarkers with high specificity for IgG4-related disease, and histopathological examination is nuanced and requires clinical correlation for accurate diagnosis. Therefore, it is crucial for clinicians to recognise the clinical phenotypes of IgG4-related disease. The disease is generally considered to have predominantly fibrotic and proliferative (or inflammatory) manifestations, with distinct clinical, serological and histopathological findings associated with each manifestation. However, the fibrotic and proliferative manifestations of this disease frequently occur together, thereby blurring this dichotomous distinction. In this Series paper, we provide a detailed overview of the clinical manifestations typical of the proliferative features of IgG4-related disease, with an emphasis on the diagnostic evaluation and differential diagnosis of each proliferative disease manifestation. In addition, we summarise the immune mechanisms underlying IgG4-related disease, suggest a framework for how to approach management and monitoring after the diagnosis is established, and highlight current unmet needs for patient care surrounding this disease.
Copyright © 2024 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of interests GK receives research support from Sanofi. YH-B receives research support from Nestlé Health Science and PACT-CP Registry; payment or honoraria for lectures or presentations from Mayo Clinic CME course, Mount Sinai Hospital, and Washington University (in St Louis); and is a member of the Scientific Advisory Board of Nestlé Health Science. DP discloses a grant from Ministero Italiano della Salute (GR-2021-12373600). CAP receives research support from Horizon Therapeutics and Sanofi. All other authors declare no competing interests.
Similar articles
-
Fibrotic phenotype of IgG4-related disease.Lancet Rheumatol. 2024 Jul;6(7):e469-e480. doi: 10.1016/S2665-9913(23)00299-0. Epub 2024 Apr 1. Lancet Rheumatol. 2024. PMID: 38574746 Review.
-
IgG4-related disease: lessons from the first 20 years.Rheumatology (Oxford). 2025 Mar 1;64(Supplement_1):i24-i27. doi: 10.1093/rheumatology/keaf008. Rheumatology (Oxford). 2025. PMID: 40071397 Review.
-
IgG4-related disease and other fibro-inflammatory conditions.Nat Rev Rheumatol. 2025 May;21(5):275-290. doi: 10.1038/s41584-025-01240-x. Epub 2025 Apr 7. Nat Rev Rheumatol. 2025. PMID: 40195520 Review.
-
[The different forms of IgG4-related disease].Ned Tijdschr Geneeskd. 2018 Aug 16;162:D2771. Ned Tijdschr Geneeskd. 2018. PMID: 30212027 Dutch.
-
IgG4-Related Disease: Current and Future Insights into Pathological Diagnosis.Int J Mol Sci. 2025 Jun 1;26(11):5325. doi: 10.3390/ijms26115325. Int J Mol Sci. 2025. PMID: 40508133 Free PMC article. Review.
Cited by
-
Update on Autoimmune Pancreatitis and IgG4-Related Disease.United European Gastroenterol J. 2025 Feb;13(1):107-115. doi: 10.1002/ueg2.12738. Epub 2024 Dec 21. United European Gastroenterol J. 2025. PMID: 39707927 Free PMC article. Review.
-
Clinical characteristics of IgG4-related retroperitoneal fibrosis in a cohort of 117 patients with idiopathic retroperitoneal fibrosis: a retrospective study.Clin Rheumatol. 2025 Feb;44(2):757-766. doi: 10.1007/s10067-024-07276-w. Epub 2025 Jan 4. Clin Rheumatol. 2025. PMID: 39755817
-
Exploring the clinical characteristics and long-term outcome of serologically active clinically quiescent IgG4-related disease: knowledge from a prospective cohort.Clin Rheumatol. 2025 Jul;44(7):2929-2940. doi: 10.1007/s10067-025-07507-8. Epub 2025 May 30. Clin Rheumatol. 2025. PMID: 40445521
-
Multiorgan involvement and circulating IgG1 predict hypocomplementaemia in IgG4-related disease.Ann Rheum Dis. 2024 Nov 14;83(12):1773-1780. doi: 10.1136/ard-2024-225846. Ann Rheum Dis. 2024. PMID: 39079893
-
IgG4-related disease for the hematologist.Hematology Am Soc Hematol Educ Program. 2024 Dec 6;2024(1):594-603. doi: 10.1182/hematology.2024000584. Hematology Am Soc Hematol Educ Program. 2024. PMID: 39644037 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources